To investigate whether immunometabolic dysregulation in CD8+Tc can be a potential mechanism underlining increased COVID-19 severity within patients with metabolic disorders, we evaluated whether COVID(+) patients in our cohort who had metabolic syndrome (see Methods for detailed classification) possessed differential immunometabolic profile. The gene discussed is CD8A; the disease is metabolic disease.